Stay updated on Optimal Tenecteplase Dose in Stroke Clinical Trial
Sign up to get notified when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.

Latest updates to the Optimal Tenecteplase Dose in Stroke Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoChange DetectedThe page now shows that the study is no longer enrolling participants, indicating recruitment is closed. The update also adds new help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the page revision to v3.6.0.SummaryDifference0.4%

- Check17 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a newer version of the page.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision metadata was updated from v3.5.3 to v3.5.4, indicating a software/content release. The update does not alter the trial details or displayed information.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page's revision label was updated from v3.5.2 to v3.5.3, indicating a newer version of the page.SummaryDifference0.0%

- Check67 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check96 days agoChange DetectedRevision: v3.5.0 replaces the previous v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Optimal Tenecteplase Dose in Stroke Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimal Tenecteplase Dose in Stroke Clinical Trial page.